title: [Inflammation in chronic kidney disease: the role of cytokines].
abstract: Chronic kidney disease (CKD) is a serious public health problem whose prevalence has increased in the last few years. Its progression is associated with high morbidity and mortality. Several factors are associated with the onset and progression of CKD, such as obesity, hypertension and diabetes mellitus. Beyond these factors, there is evidence of a pathophysiological role for inflammation in CKD. Several cytokines and chemokines have been detected in the plasma and urine of patients at early stages of CKD, and have also been related to CKD complications. The expression of these mediators and renal injury may be influenced by drugs such as angiotensin-converting enzyme inhibitors, statins and antagonists of cytokine receptors. Modulation of the immune-inflammatory response can become a target for CKD treatment. The aim of this study was to review the scientific evidence on the role of inflammation in CKD, especially the effects of cytokines and chemokines.
authors: Universidade Federal de Minas Gerais.
authors: Heloisa R
authors: HR
authors: Vianna
authors: Cristina Maria Bouissou Morais
authors: CM
authors: Soares
authors: Marcelo S
authors: MS
authors: Tavares
authors: Mauro Martins
authors: MM
authors: Teixeira
authors: Ana Cristina Simoes e
authors: AC
authors: Silva
mesh_terms: D015415:Biomarkers; D016207:Cytokines / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000276:immunology*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000276:immunology*; D007678:Kidney Glomerulus; D012084:Renin-Angiotensin System / Q000502:physiology
chemical_list: D015415:Biomarkers; D016207:Cytokines